4-Hydroxycitrulline



Compound IDCDAMM00237
Common name4-Hydroxycitrulline
IUPAC name2-amino-5-(carbamoylamino)-4-hydroxypentanoic acid
Molecular formulaC6H13N3O4

Experimental data

Retention time35.3
Adduct[M+H]+
Actual mz192.098
Theoretical mz192.098
Error3.22
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.315

Identifiers and class information

Inchi keyWSFLFFUIEVIDJY-UHFFFAOYNA-N
SmilesC(C(CNC(=O)N)O)C(C(=O)O)N
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)191.186
Computed dipole moment(dipole)10.666
Total solvent accessible surface area (SASA)406.864
Hydrophobic component of SASA (FOSA)88.248
Hydrophilic component of SASA (FISA)318.616
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)640.419
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)6.7
Free energy of solvation of dipole (dip^2/V)0.177642
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0435687
Globularity descriptor (glob)0.883131
Predicted polarizability in cubic angstroms (QPpolrz)14.981
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.888
Predicted octanol/gas partition coefficient (QPlogPoct)21.172
Predicted water/gas partition coefficient (QPlogPw)20.778
Predicted octanol/water partition coefficient (QPlogPo/w)-4.672
Predicted aqueous solubility (QPlogS)0.896
Conformation-independent predicted aqueous solubility (CIQPlogS)0.831
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.967
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.312
Predicted brain/blood partition coefficient (QPlogBB)-2.183
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.227
Predicted skin permeability, log Kp (QPlogKp)-8.782
PM3 calculated ionization potential (IP(ev))9.718
PM3 calculated electron affinity (EA(eV))-0.822
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.499
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)35.194
Van der Waals surface area (PSA)160.669
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29475NOS1Nitric-oxide synthase, brainT16117SEA
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
P29474NOS3Nitric-oxide synthase, endothelialT06046SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
P42261GRIA1Glutamate receptor ionotropic, AMPA 1T33584SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
P42262GRIA2Glutamate receptor ionotropic, AMPA 2T42392SEA
Q16719KYNUKynureninaseT99912SEA
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
Q9ULA0DNPEPAspartyl aminopeptidaseT45287SEA
P43003SLC1A3Excitatory amino acid transporter 1T86582SEA
Q9UPY5SLC7A11Cystine/glutamate transporterT11615SEA
P00480OTCOrnithine transcarbamylaseT52098SEA
P42263GRIA3Glutamate receptor AMPA 3T62391SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16117DI0173Headache[ICD-11: 8A80-8A84]P29475NOS1
T16117DI0264Migraine[ICD-11: 8A80]P29475NOS1
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T06046DI0287Myocardial infarction[ICD-11: BA41-BA43]P29474NOS3
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T33584DI0298Neuropathy[ICD-11: 8C0Z]P42261GRIA1
T42392DI0298Neuropathy[ICD-11: 8C0Z]P42262GRIA2
T99912DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q16719KYNU
T99912DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q16719KYNU
T45287DI0190Hypertension[ICD-11: BA00-BA04]Q9ULA0DNPEP
T11615DI0054Body-focused behaviour disorder[ICD-11: 6B25]Q9UPY5SLC7A11
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC
T62391DI0298Neuropathy[ICD-11: 8C0Z]P42263GRIA3

Copyright © 2025